Monsanto Co. (MON) Stake Decreased by Dividend Assets Capital LLC
Dividend Assets Capital LLC cut its stake in Monsanto Co. (NYSE:MON) by 13.7% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 542,934 shares of the company’s stock after selling 86,500 shares during the period. Dividend Assets Capital LLC owned 0.12% of Monsanto worth $56,145,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Glenmede Trust Co. NA boosted its stake in Monsanto by 24.9% in the first quarter. Glenmede Trust Co. NA now owns 147,165 shares of the company’s stock worth $12,911,000 after buying an additional 29,367 shares during the last quarter. Mn Services Vermogensbeheer B.V. purchased a new stake in Monsanto during the first quarter worth about $846,000. Virginia Retirement System purchased a new stake in Monsanto during the first quarter worth about $626,000. IFP Advisors Inc boosted its stake in Monsanto by 38.0% in the first quarter. IFP Advisors Inc now owns 7,121 shares of the company’s stock worth $625,000 after buying an additional 1,962 shares during the last quarter. Finally, Cortland Associates Inc. MO boosted its stake in Monsanto by 2.1% in the first quarter. Cortland Associates Inc. MO now owns 151,363 shares of the company’s stock worth $13,281,000 after buying an additional 3,159 shares during the last quarter. 79.06% of the stock is owned by institutional investors and hedge funds.
Monsanto Co. (NYSE:MON) traded up 0.30% during midday trading on Wednesday, reaching $102.56. The company’s stock had a trading volume of 3,103,305 shares. The firm has a 50 day moving average price of $105.47 and a 200-day moving average price of $100.91. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26. The firm has a market cap of $44.88 billion, a P/E ratio of 45.14 and a beta of 1.24.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.40 by $0.23. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.49 billion. During the same period in the prior year, the business posted $2.39 earnings per share. The firm’s revenue for the quarter was down 8.5% compared to the same quarter last year. On average, analysts forecast that Monsanto Co. will post $4.46 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. Monsanto’s dividend payout ratio is presently 89.26%.
A number of research firms recently issued reports on MON. Deutsche Bank AG reissued a “buy” rating and set a $100.00 price objective on shares of Monsanto in a research report on Wednesday, June 1st. S&P Equity Research reissued a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. JPMorgan Chase & Co. reissued a “hold” rating on shares of Monsanto in a research report on Thursday, June 30th. Goldman Sachs Group Inc. raised Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price objective for the company in a research report on Tuesday. Finally, Zacks Investment Research cut Monsanto from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto presently has an average rating of “Buy” and a consensus target price of $114.31.
In related news, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.